UNICREDIT BANK/CALL/MERCK/195/0.1/18.12.24 Stock

Warrant

DE000HC88EH8

Delayed Deutsche Boerse AG 02:48:44 2024-07-18 am EDT
0.17 EUR -5.56% Intraday chart for UNICREDIT BANK/CALL/MERCK/195/0.1/18.12.24
Current month-25.00%
1 month-70.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-18 0.17 -5.56%
24-07-17 0.18 +5.88%
24-07-16 0.17 +6.25%
24-07-15 0.16 -20.00%
24-07-12 0.2 +5.26%

Delayed Quote Deutsche Boerse AG

Last update July 18, 2024 at 02:48 am EDT

More quotes

Static data

Product typeWarrant Plain-Vanilla
Buy / SellCALL
Underlying MERCK KGAA
IssuerLogo Issuer UniCredit UniCredit
WKN HC88EH
ISINDE000HC88EH8
Date issued 2023-07-26
Strike 195
Maturity 2024-12-18 (154 Days)
Parity 10 : 1
Emission price 0.98
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.29
Lowest since issue 0.13
Spread 0.04
Spread %19.05%

Company Profile

Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Sector
-
More about the company

Ratings for Merck KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Merck KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
154.6 EUR
Average target price
181.4 EUR
Spread / Average Target
+17.40%
Consensus